UV Germi S.A. (ALUVI.PA)
Saint-Viance, FR
UV Germi S.A. specializes in the development, production, and distribution of ultraviolet (UV) purification systems for treating air, water, and various surfaces. The company's operations span France, the broader European continent, the Middle East, and North Africa. Its diverse product line addresses critical water applications, including potable water, municipal wastewater, public swimming pool water, rainwater, and industrial water requirements for the food processing, pharmaceutical, and cosmetics sectors. Additionally, UV Germi S.A. provides comprehensive after-sales support, encompassing technical assistance for equipment installation and ongoing maintenance. Established in 2009, the company is headquartered in Saint-Viance, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.21% | -1.63% | +0.84% | -20.98% | -16.90% | -17.75% | +1.26% | -45.23% | -77.26% | -56.81% | -56.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%-20.1% Q4'25: -12.2% (vs Q4'23)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%-80.9% Q4'25: +12.1% (vs Q4'23)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%+7.5% Q4'25: +0.0% (vs Q4'23)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%+0.4% Q4'25: -9.9% (vs Q4'23)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%+0.6% Q4'25: -21.3% (vs Q4'23)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%-24.3% ★ Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×0.54× ★ Q4'25: -0.51× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.34M
est: 5.10M (+4.7%)
|
6.42M
est: 6.70M (-4.2%)
|
6.66M
est: 7.10M (-6.2%)
|
6.32M
est: 6.30M (+0.3%)
|
7.16M
est: 7.20M (-0.5%)
|
8.04M
est: 8.03M (+0.0%)
|
8.51M
est: 8.47M (+0.5%)
|
6.81M
est: 6.81M (-0.1%)
|
7.83M
7.83M – 7.83M
+15.0% YoY
|
8.85M
8.85M – 8.85M
+13.0% YoY
|
| EBITDA |
-255.5K
est: 195.2K (-230.9%)
|
140.9K
est: 256.5K (-45.1%)
|
476.3K
est: 271.8K (+75.3%)
|
-718.1K
est: 241.1K (-397.8%)
|
330.4K
est: 275.6K (+19.9%)
|
628.5K
est: 307.5K (+104.4%)
|
929.5K
est: 311.3K (+198.6%)
|
434.8K
est: 250.3K (+73.7%)
|
287.8K
287.8K – 287.8K
+15.0% YoY
|
325.2K
325.2K – 325.2K
+13.0% YoY
|
| EBIT |
-444.6K
est: -27.2K (-1,537.3%)
|
-68.7K
est: -35.7K (-92.6%)
|
206.8K
est: -37.8K (+647.0%)
|
-1.03M
est: -33.5K (-2,974.0%)
|
16.9K
est: -38.3K (+144.1%)
|
288.2K
est: -42.8K (+773.8%)
|
573.0K
est: -90.3K (+734.8%)
|
29.9K
est: -72.6K (+141.2%)
|
-83.5K
-83.5K – -83.5K
-15.0% YoY
|
-94.3K
-94.3K – -94.3K
-13.0% YoY
|
| Net Income |
-361.2K
est: -445.2K (+18.9%)
|
95.6K
est: 95.4K (+0.3%)
|
410.3K
est: 508.8K (-19.4%)
|
-869.5K
est: -206.7K (-320.7%)
|
66.0K
|
290.1K
est: 445.2K (-34.8%)
|
709.9K
est: 529.4K (+34.1%)
|
101.3K
est: 192.5K (-47.4%)
|
457.2K
457.2K – 457.2K
+137.5% YoY
|
505.4K
505.4K – 505.4K
+10.5% YoY
|
| SGA |
1.30M
est: 39.7K (+3,161.0%)
|
2.11M
est: 52.2K (+3,952.5%)
|
65.0K
est: 55.3K (+17.6%)
|
3.9K
est: 49.1K (-92.0%)
|
121.9K
est: 56.1K (+117.4%)
|
—
est: 62.6K (-100.0%)
|
98.3K
est: 49.4K (+98.8%)
|
—
est: 39.7K (-100.0%)
|
45.7K
45.7K – 45.7K
+15.0% YoY
|
51.6K
51.6K – 51.6K
+13.0% YoY
|
| EPS |
-0.14
est: -0.14 (+0.0%)
|
0.04
est: 0.03 (+24.7%)
|
0.16
est: 0.16 (+0.0%)
|
-0.34
est: -0.07 (-423.1%)
|
0.02
|
0.09
est: 0.14 (-34.9%)
|
0.22
est: 0.22 (+0.0%)
|
0.04
est: 0.08 (-47.4%)
|
0.19
0.19 – 0.19
+137.5% YoY
|
0.21
0.21 – 0.21
+10.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 2/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sandrine Bordas | Deputy Chief Executive Officer & Director | — | female |
| Willy Fortunato | Chief Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALUVI.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
